The stock price of Bone Biologics Corp (NASDAQ: BBLG) – a developer of orthobiologic products for spine fusion markets – increased by over 30% pre-market today. Investors are responding positively to Bone Biologics announcing that Jeffrey Frelick, the company’s president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 – 13, 2022.
A pre-recorded presentation is going to be available starting Monday, January 10 at 7:00 a.m. Eastern time. And interested parties may access a webcast of the presentation on the investor relations section of the company’s website.
https://pulse2.com/bone-biologics-stock-nasdaq-bblg-why-the-price-jumped-today/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.